179692-08-1 Usage
Description
Ethyl 4-iodo-1H-pyrazole-5-carboxylate is a chemical compound characterized by the molecular formula C7H8IN3O2. It is a pyrazole derivative, featuring a five-membered aromatic ring with two nitrogen atoms, an ethyl ester group attached to the carboxylate moiety, and an iodine atom at the 4-position of the pyrazole ring. Ethyl 4-iodo-1H-pyrazole-5-carboxylate is notable for its potential applications in organic synthesis and medicinal chemistry, attributed to its distinctive structural attributes and reactivity. It serves as a valuable building block for the creation of pharmacologically active compounds and as a precursor in the synthesis of various functionalized pyrazole derivatives. However, it is crucial to handle this chemical with care, adhering to appropriate safety measures and guidelines.
Uses
Used in Organic Synthesis:
Ethyl 4-iodo-1H-pyrazole-5-carboxylate is utilized as a key intermediate in organic synthesis for the preparation of a variety of chemical compounds. Its unique structural features and reactivity make it a versatile component in the synthesis of complex organic molecules.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, Ethyl 4-iodo-1H-pyrazole-5-carboxylate is employed as a building block for the development of new pharmaceuticals. Its structural properties allow for the creation of compounds with potential therapeutic applications.
Used in the Synthesis of Pharmacologically Active Compounds:
Ethyl 4-iodo-1H-pyrazole-5-carboxylate is used as a precursor in the synthesis of pharmacologically active compounds, contributing to the development of new drugs with potential therapeutic benefits.
Used in the Preparation of Functionalized Pyrazole Derivatives:
Ethyl 4-iodo-1H-pyrazole-5-carboxylate is also used in the preparation of various functionalized pyrazole derivatives, which can have diverse applications in different chemical and pharmaceutical industries.
Used in Research and Development:
Ethyl 4-iodo-1H-pyrazole-5-carboxylate is utilized in research and development settings to explore its potential applications and to understand its chemical properties and reactivity, which can lead to the discovery of new uses and applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 179692-08-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,9,6,9 and 2 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 179692-08:
(8*1)+(7*7)+(6*9)+(5*6)+(4*9)+(3*2)+(2*0)+(1*8)=191
191 % 10 = 1
So 179692-08-1 is a valid CAS Registry Number.
179692-08-1Relevant articles and documents
DIHYDROPYRAZOLOPYRAZINONE DERIVATIVES
-
Paragraph 0171, (2020/01/02)
PROBLEM TO BE SOLVED: To provide compounds useful as therapeutic agents for disease involving metabotropic glutamate receptor subtype 2 and/or metabotropic glutamate receptor subtype 3. SOLUTION: The invention provides compounds represented by formula (1)
CYANOPYRROLIDINES AS DUB INHIBITORS FOR THE TREATMENT OF CANCER
-
Page/Page column 73-74, (2017/02/09)
The present invention relates to novel compounds and method for the manufacture of inhibitors of deubiquitylating enzymes (DUBs). In particular, the invention relates to the inhibition of ubiquitin C- terminal hydrolase L1 (UCHL1) and ubiquitin C-terminal hydrolase 30 or ubiquitin specific peptidase 30 (USP30). The invention further relates to the use of DUB inhibitors in the treatment of cancer and conditions involving mitochondrial dysfunction. Compounds of the invention include compounds having the formula (I) or a pharmaceutically acceptable salt thereof, wherein R1,R2,R3,R4,R5,R6,R7,R8 and R9 are as defined herein.
Novel Compounds as Autotaxin Inhibitors and Pharmaceutical Compositions Comprising the Same
-
Paragraph 1335-1338, (2018/05/17)
The present invention relates to a novel autotaxin inhibitor compound for preventing and treating disease or symptoms due to an increase in concentration of lysophosphatidic acid or activation of autotaxin. The present invention further relates to a pharmaceutical composition containing the same. The novel compound of the present invention is an autotaxin inhibitor which inhibits production of lysophosphatidic acid, and thus is useful for treating or preventing cardiovascular disease, cancer, metabolic disease, kidney disease, liver disease, inflammatory diseases, nervous disease, respiratory disease, desmoid disease, eye disease, cholestatic symptoms, other types of chronic pruritus or acute, or chronic rejection of transplanted organs.COPYRIGHT KIPO 2017
